The Ageproof Podcast - Unlocking Chronic Disease Through the Microbiome: Martha Carlin’s Revolutionary Parkinson’s Journey
by Kevin Danielson April 14, 2025
What happens when a business strategist refuses to accept a diagnosis—and instead decides to rewrite the entire paradigm of chronic illness?
In this mind-expanding episode, Piers speaks with Martha Carlin, founder of BiotiQuest®, about her extraordinary transformation from systems analyst to citizen scientist. Motivated by her husband’s Parkinson’s diagnosis, Martha dove into biochemistry, soil biology, and microbiome science—eventually developing Sugar Shift®, a groundbreaking probiotic that reshapes sugar metabolism and supports brain health.
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.